微信直播

ESTS前主席Leschber & IASLC理事De Leyn:E-Bus, 纵隔镜 or VALAM?

Published at: 2015年第1卷第S1期

阎石 , 黎少灵
关键词:

编者按:第24届亚洲胸心外科协会(ASCVTS)暨第4届亚洲单孔胸腔镜论坛(ASPVS)于2016年4月6-10日在台北国际会议中心举行。正式大会在4月4月8日开幕,前两天会议分别为海峡两岸交流会和 AATS postgraduate course。

本次会议也活跃着中国讲者的身影。值得一提的是,在会议期间,陈海泉教授和庄建教授当选新一届 ASCVTS 协会 council member,这是中国专家参与 ASCVTS 事务的重大进展。而对于年轻医师来说,能够与国际大咖同台,展示自己的科研工作,机会难能可贵。    

秉承着快乐学术、促进交流的会议报道宗旨,AME 出版社以展台为线下基地,在会议期间展开了一场“East meets West, junior meets Senior”的对话运动,即由国内优秀中青年医师组成的AME特邀记者团与国际学科意见领袖(Key opinion leader)就相关热点话题进行访谈对话。

AME 特邀记者、来自北京大学肿瘤医院的阎石医师与 ESTS 前任主席、德国胸外科协会主席 Gunda Leschber 教授,IASLC 理事会成员 Paul De Leyn 教授就 E-Bus, EUS, 纵隔镜 or VALAM 的问题以采访的形式进行探讨。

阎石医师对话 Leschber 教授和 De Leyn 教授


采访问题

1.As is known, the procedure of E-Bus, EUS or mediastinoscopy is time-consuming. For a patient clinically confirmed as in N1 stage, whose PET/CT scan shows no FDG uptake in the mediastinal lymph nodes, could the patient skip E-Bus and mediastinoscopy in further examination?

众所周知,E-Bus, EUS和纵隔镜均是耗时的,那对于临床分期N1的患者,如果他的PET/CT提示纵隔淋巴结没有FDG摄取,是否该患者可以免除EBus和纵隔镜检查呢?

2.For the concern of the accuracy rate of identifying lymph node metastasis by using E-Bus and mediastinoscopy, would there be any controversy about the unnecessary medical cost if E-Bus and mediastinoscopy were found negative? E-Bus和纵隔镜经常被用于判断纵隔淋巴结转移。但很多时候,E-Bus和纵隔镜结果为阴性,这样是否会给患者造成不必要的医疗负担?

3.Prof. Leschber has introduced about VAMLA in her talk. Would it be hard to make complete dissection of mediastinal lymph nodes given the limited space of VAMLA procedure?

由于VAMLA操作空间狭小,是否很难保证纵隔淋巴结切除的完整性?

4.For pathologically N2 patients, what is the indication for conventional mediastionscopy and VAMLA? Will the radical resection of lymph node provide survival benefit for patients? 

对于病理N2的患者,什么情况下需要传统的纵隔镜检查或VAMLA?纵隔淋巴结的彻底切除是否会带来生存获益?

5.It is recommended by European Society of Thoracic Surgeons (ESTS) to sample at least three different stations of mediastinal nodes. Considering the potential risk of needle aspiration, can we perform a selective biopsy based on the location of tumor? For a patient with tumor located at the upper lobe, does he need biopsy in the 9th station of mediastinal lymph node?

ESTS建议E-Bus活检至少三站纵隔淋巴结,考虑到穿刺的风险,能否根据肿瘤的位置选择性进行纵隔淋巴结的穿刺。例如对于纵隔第9组淋巴结,上叶肿瘤患者,是否可以不做穿刺?

 

受访专家

Gunda Leschber, M.D

  • 2005, Member of Board of the German Association for Thoracic Surgery (DGT) 

  • 2006, Spokesperson for ‘FiT’ section (Women in Thoracic Surgery) of the DGT  

  • 2007, Member of the Board of the European Society of Thoracic Surgeons, ESTS;Member of the Board of the Professional Association of German Surgeons (BDC);Leader of the lung carcinoma project group at Berlin Tumour Centre;Deputy Chair of the Tumour Centre, Berlin-Buch      

  • 2010/2011, President of the ESTS

  • Vice-President German Society of Thoracic Surgerey (2014)

  • Research interest: Video-Mediastinscopy/VAMLA, NOTES, Metastasectomy, Lasersurgery, Minimal-invasive Surgery (VATS)

Paul De Leyn, M.D, Ph.D

  • Thoracic Surgeon, Regent for Europe, University Hospitals, Leuven, Belgium

  • Professor (part-time) Faculty of Medicine

  • Head of Surgery Teaching Methodology and Practicals

  • Member (as senior academic staff) of the Council of the Faculty of Medicine

  • Member of the Council of the Department of Clinical and Experimental Medicine

  • Member in an advisory capacity of the Board of the Department of Clinical and Experimental Medicine

  • Member of Council of Regent, International Association for the Study of Lung Cancer (IASLC)

AME 特邀记者|阎石,北京大学肿瘤医院胸外科。 

编辑|黎少灵,AME出版社。

点击“链接”,可浏览 Journal of Thoracic Disease 杂志关于胸部疾病内镜技术过去、现在和未来发展的专刊。http://jtd.amegroups.com/issue/view/160

doi:10.3978/kysj.2014.1.1812

comments powered by Disqus

附件